The Chiari malformation type I (CM-I) has been associated with sleep-disordered breathing, especially central sleep apnea syndrome. We
report the case of a 44-year-old female with CM-I who was referred to our sleep laboratory for suspected sleep apnea. The patient had
undergone decompressive surgery 3 years prior. An arterial blood gas analysis showed hypercapnia. Polysomnography showed a respiratory
disturbance index of 108 events/h, and all were central apnea events. Treatment with adaptive servo-ventilation was initiated, and central
apnea was resolved. This report demonstrates the efficacy of servo-ventilation in the treatment of central sleep apnea syndrome associated
with alveolar hypoventilation in a CM-I patient with a history of decompressive surgery. The Chiari malformation type I (CM-I) is
characterized by caudal displacement of the cerebellum and by herniation of the cerebellar tonsils through the foramen magnum.( 1 ) This
malformation has been associated with sleep-disordered breathing, especially central sleep apnea syndrome.( 2 ) Treatment of symptomatic
CM-I consists of surgical decompression, which usually resolves the associated sleep-disordered breathing.( 3 ) We report a case of severe
central sleep apnea syndrome in a female CM-I patient with a history of decompressive surgery who was treated effectively with adaptive
servo-ventilation (ASV). A 44-year-old female patient diagnosed with CM-I in 2008 (Figure 1A) underwent decompressive surgery of the
posterior cranial fossa. She underwent suboccipital craniectomy, laminectomy of C1 and C2, and duraplasty. Her postoperative complications
included cerebrospinal fluid fistula, which required reoperation and application of biological glue, and surgical wound infection, which was
treated with debridement. Twelve months after surgery, the patient presented with worsening of neurological symptoms, including occipital
headaches, dizziness, gait imbalance, left facial paresis, and dysphagia for liquids. Magnetic resonance imaging showed bony malformation of
the craniovertebral junction associated with a syringomyelic cavity involving C2 and C3 (Figure 1B). Additional surgical intervention was
ruled out because of the associated risk of respiratory depression. Three years after surgery, the patient was referred to our sleep
laboratory for suspected sleep apnea. She reported nonrestorative sleep and morning headaches, but she had no daytime sleepiness (Epworth
score of 4) or symptoms suggestive of restless legs syndrome or narcolepsy. Additional information obtained from the patient's family
confirmed the presence of snoring and witnessed apneas. The patient had a history of hypothyroidism and received levothyroxine regularly.
She was a nonsmoker and did not drink alcohol. Figure 1In A, presurgical magnetic resonance imaging scan of the brain showing bony
malformation of the craniovertebral junction associated with basilar impression and a shortened clivus. Low cerebellar tonsils (Chiari
malformation type I), but without evidence of syringomyelia. In B, postsurgical magnetic resonance imaging scan of the brain (T2) showing
bony malformation of the craniovertebral junction associated with syringomyelia at the level of C2 and C3. Physical examination revealed
that the patient had a body mass index of 34 kg/m2, a systemic blood pressure of 127/73 mmHg, and a neck circumference of 46 cm. In
addition, she had a hypertrophic soft palate (Mallampati class II), but she had no facial dysmorphisms. The remainder of the physical
examination was normal. A chest X-ray was unremarkable. There was no evidence of cardiovascular comorbidities (an echocardiogram and a
Holter examination were unremarkable). Thyroid function was normal. An arterial blood gas analysis showed severe hypoxemia with mild
hypercapnia (FiO2 = 0.21; pH = 7.35; PaO2 = 51 mmHg; PaCO2 = 56 mmHg; and SaO2 = 89%). Respiratory function test results revealed a slight
reduction in FVC, a reduction in expiratory reserve volume and a preserved TLC. Polysomnography showed low sleep efficiency (44.4%), with
333 central respiratory events, a respiratory disturbance index of 108 events/h, and 27.6% of sleep time with oxyhemoglobin saturation < 90%
(Figure 2). Figure 2Baseline polysomnogram showing central apneas. The patient started treatment for central sleep apnea syndrome with ASV
(S9 Autoset CS(tm); ResMed Corp., San Diego, CA, USA), with a maximum pressure support of 15 cmH2O, a minimum pressure support of 5 cmH2O,
an expiratory pressure of 8 cmH2O, and an RR of 15 breaths/min. After six months of treatment, polysomnography under ASV showed that the
respiratory disturbance index improved from 108 events/h to 4.8 events/h and that the patient spent 1.4% of sleep time with oxyhemoglobin
saturation < 90% (Figure 3). In addition, there was improvement in gas exchange (FiO2 = 0.21; pH = 7.36; PaO2 = 69 mmHg; PaCO2 = 46 mmHg;
and SaO2 = 93%). Figure 3Polysomnogram under servo-ventilation, showing resolution of the central apneas. The CM-I has been defined as >
5-mm caudal displacement of the cerebellar tonsils through the foramen magnum and is usually associated with a volumetrically reduced
posterior fossa.( 1 ) For a diagnosis, these radiological criteria should be interpreted in the clinical context, and magnetic resonance
imaging is the most useful imaging tool. The respiratory center that controls breathing is located in the medulla oblongata, at the level of
the craniocervical junction, and can be affected in this disease, thereby leading to respiratory disorders, especially during sleep. ( 4 )
Studies in the literature have reported a high prevalence of sleep-disordered breathing in patients with CM.( 5 , 6 ) Although most reports
in adults describe especially central sleep apneas, mixed and obstructive apneas are also seen.( 7 , 8 ) Central apneas might result from
direct compression of the central respiratory components, compression of cranial nerve pairs IX and X, and afferent nerve lesion caused by
syringomyelic cavities.( 9 ) Hypoventilation is defined as sustained oxygen desaturation that is not associated with obstructive apneas,
hypopneas, or periodic breathing.( 10 ) Patients with daytime hypercapnia, mainly because of neuromuscular disease or ventilatory control
abnormalities (obesity hypoventilation syndrome and central alveolar hypoventilation), may also have central apneas during sleep.( 11 )
Central events are characterized by a temporary cessation of the neural respiratory drive during sleep, resulting in a decrease in
ventilation and changes in gas exchange.( 12 ) In general, central apneas during sleep in patients with hypercapnia should be distinguished
from those occurring in patients with normocapnia or hypocapnia. Hypercapnic central sleep apnea overlaps with hypoventilation syndromes and
is considered an integral part of sleep hypoventilation syndrome.( 11 ) In the case described here, there were changes in respiratory
function, including a slight reduction in FVC accompanied by a reduction in expiratory reserve volume. In obese patients, there is
respiratory mechanics impairment that causes changes in pulmonary function, such as increased work of breathing and reduced lung volumes.
The ventilatory restriction imposed by obesity is usually mild and is attributed to the mechanical effects that accumulation of adipose
tissue has on the diaphragm and chest wall: diaphragmatic excursion is impaired and chest compliance is decreased.( 13 ) The reduction in
expiratory reserve volume may be detectable even in modestly overweight patients. In patients with morbid obesity, this change may be
accompanied by a reduction in TLC and functional residual capacity.( 14 ) Some obese patients have alveolar hypoventilation. The mechanism
through which obesity leads to hypoventilation is complex and has yet to be fully understood. Several mechanisms have been proposed,
including changes in respiratory mechanics, decreased central responses to hypercapnia and hypoxia, and neurohormonal changes, such as
resistance to leptin.( 15 ) Obesity hypoventilation syndrome is defined as a combination of obesity (body mass index â‰¥ 30 kg/m2), daytime
hypercapnia, and different types of sleep-disordered breathing in the absence of other conditions that may cause alveolar hypoventilation
(obstructive or restrictive lung diseases, diseases of the chest wall, and neuromuscular diseases).( 16 ) Patients with neurological
disorders, including CM, may have central hypoventilation.( 17 ) However, alveolar hypoventilation associated with central apneas is not
common in CM-I, and, in the present case, it is not possible to exclude the role of obesity in the changes found on arterial blood gas
analysis. Decompressive surgery usually results in a decreased number of respiratory events during sleep and reduces sleep fragmentation in
a significant number of patients, with the effects being more pronounced in those with central apneas.( 3 ) However, there are reports of
the emergence of central apneas after surgery.( 18 ) ASV is a form of closed-loop mechanical ventilation, pressure preset, and volume or
flow cycled. It alleviates central apneas by providing dynamic (breath-by-breath) adjustment of inspiratory pressure support with a back-up
rate to normalize breathing patterns. The efficacy of ASV has been established especially in the treatment of central sleep apnea syndrome
associated with congestive heart failure. In central sleep apnea syndrome associated with neurological disorders (without Cheyne-Stokes
respiration), the role of ASV has yet to be well established.( 19 ) The clinical case reported here demonstrates the efficacy of ASV in the
treatment of central sleep apnea syndrome associated with alveolar hypoventilation in a CM-I patient, since there was complete resolution of
the central events and a significant improvement in gas exchange. In addition, the case suggests that ASV may be efficacious in the
treatment of central sleep apnea in CM-I patients with a history of decompressive surgery. We have found only one similar case reported in
the published literature. ( 20 ) In conclusion, ASV may be an alternative to decompressive surgery in the treatment of central sleep apnea
in CM-I patients We would like to thank Dr. Nuno Canto Moreira for his contribution in the analysis of the magnetic resonance imaging scans.
Financial support: None Study carried out in the Department of Pulmonology, Tondela-Viseu Hospital Center, Viseu, Portugal A malformaÃ§Ã£o de
Chiari tipo I (MC-I) tem sido associada a distÃºrbios respiratÃ³rios do sono, sobretudo Ã  sÃ­ndrome de apneia central do sono. Apresentamos o
caso de uma paciente do sexo feminino de 44 anos de idade com MC-I que foi encaminhada Ã  nossa unidade de sono por suspeita de apneia do
sono. A paciente havia sido submetida a cirurgia descompressiva 3 anos antes. A gasometria arterial mostrou hipercapnia. A polissonografia
revelou um Ã­ndice de distÃºrbio respiratÃ³rio de 108 eventos/h, sendo todos os eventos apneias centrais. Foi iniciado tratamento com
servoventilaÃ§Ã£o adaptativa e houve resoluÃ§Ã£o da apneia central. Este relato demonstra a eficÃ¡cia da servoventilaÃ§Ã£o no tratamento da
sÃ­ndrome de apneia central do sono associada Ã  hipoventilaÃ§Ã£o alveolar em uma paciente com MC-I previamente submetida a cirurgia
descompressiva. A malformaÃ§Ã£o de Chiari tipo I (MC-I) Ã© caracterizada pelo deslocamento caudal do cerebelo e pela herniaÃ§Ã£o das amÃ­gdalas
cerebelares atravÃ©s do forÃ¢men magno.( 1 ) Essa malformaÃ§Ã£o tem sido associada a distÃºrbios respiratÃ³rios do sono, sobretudo Ã  sÃ­ndrome de
apneia central do sono. ( 2 ) O tratamento sintomÃ¡tico da MC-I consiste na descompressÃ£o cirÃºrgica, a qual frequentemente resolve o
distÃºrbio respiratÃ³rio do sono associado.( 3 ) Relatamos um caso de sÃ­ndrome de apneia central do sono grave numa doente com MC-I submetida
previamente a cirurgia descompressiva, que foi tratada de forma eficaz com servoventilaÃ§Ã£o adaptativa (SVA). Paciente do sexo feminino de 44
anos de idade com diagnÃ³stico de MC-I em 2008 (Figura 1A) foi submetida a cirurgia descompressiva da fossa posterior do crÃ¢nio. Foram
realizadas craniectomia suboccipital, laminectomia C1-C2 e duroplastia. No pÃ³s-operatÃ³rio, registraram-se as seguintes complicaÃ§Ãµes: fÃ­stula
de liquor, com necessidade de reintervenÃ§Ã£o com aplicaÃ§Ã£o de cola biolÃ³gica, e infecÃ§Ã£o da ferida operatÃ³ria, que motivou limpeza cirÃºrgica.
Doze meses apÃ³s a cirurgia, verificou-se um agravamento dos sintomas neurolÃ³gicos com cefaleias occipitais, vertigens, desequilÃ­brio na
marcha, paresia facial esquerda e disfagia para lÃ­quidos. Foi realizada ressonÃ¢ncia magnÃ©tica que mostrou uma malformaÃ§Ã£o Ã³ssea na junÃ§Ã£o
craniovertebral associada a uma cavidade siringomiÃ©lica de C2 a C3 (Figura 1B). Um novo tratamento cirÃºrgico nÃ£o foi efetuado dado o risco
associado de depressÃ£o respiratÃ³ria. TrÃªs anos apÃ³s a cirurgia, a paciente foi referenciada Ã  nossa unidade de sono por suspeita de apneia
do sono. Referia sono nÃ£o reparador e cefaleias matinais, mas nÃ£o apresentava hipersonolÃªncia diurna (pontuaÃ§Ã£o de 4 na escala de Epworth),
nem sintomas sugestivos de sÃ­ndrome de pernas inquietas ou de narcolepsia. Segundo informaÃ§Ã£o complementar dos familiares, a paciente
apresentava roncopatia e apneias presenciadas. A paciente apresentava histÃ³ria de hipotireoidismo, sendo medicada regularmente com
levotiroxina, e nÃ£o apresentava hÃ¡bitos tabÃ¡gicos ou etÃ­licos. Figura 1Em A, imagem de ressonÃ¢ncia magnÃ©tica cerebral prÃ©-cirurgia
demonstrando malformaÃ§Ã£o Ã³ssea da junÃ§Ã£o craniovertebral associada a impressÃ£o basilar e clivus encurtado. AmÃ­gdalas cerebelares baixas
(MalformaÃ§Ã£o de Chiari tipo I), mas sem evidÃªncia de siringomielia. Em B, imagem de ressonÃ¢ncia magnÃ©tica cerebral (T2) pÃ³s-cirurgia
mostrando uma malformaÃ§Ã£o Ã³ssea na junÃ§Ã£o craniovertrebral em associaÃ§Ã£o a siringomielia ao nÃ­vel de C2 e C3. Ao exame fÃ­sico, seu Ã­ndice de
massa corpÃ³rea era de 34 kg/m2, a pressÃ£o arterial sistÃªmica era de 127/73 mmHg, o perÃ­metro cervical era de 46 cm, apresentando hipertrofia
do palato mole (classe II no escore de Mallampati), mas sem dismorfias faciais. O restante do exame era normal. A radiografia de tÃ³rax nÃ£o
mostrou alteraÃ§Ãµes. NÃ£o havia evidÃªncia de comorbidades cardiovasculares (ecocardiograma e exame de Holter sem alteraÃ§Ãµes). A funÃ§Ã£o da
tireoide era normal. A gasometria arterial indicava hipoxemia grave com hipercapnia (FiO2 = 0,21; pH = 7,35; PaO2 = 51 mmHg; PaCO2 = 56
mmHg; e SaO2 = 89%). O estudo funcional respiratÃ³rio revelou uma diminuiÃ§Ã£o leve da CVF com diminuiÃ§Ã£o do volume de reserva expiratÃ³ria e
CPT preservada. A polissonografia mostrou baixa eficiÃªncia do sono (44,4%) com 333 eventos respiratÃ³rios centrais, um Ã­ndice de distÃºrbio
respiratÃ³rio de 108 eventos/h e um tempo de registro com saturaÃ§Ã£o da oxi-hemoglobina < 90% de 27,6% (Figura 2). Figura 2Registro
polissonogrÃ¡fico inicial exibindo apneias centrais. A paciente iniciou tratamento com SVA com um aparelho Autoset CS S9(tm) (ResMed Corp.,
San Diego, CA, EUA), com parÃ¢metros de pressÃ£o de suporte mÃ¡xima de 15 cmH2O, pressÃ£o de suporte mÃ­nima de 5 cmH2O, pressÃ£o expiratÃ³ria de 8
cmH2O e FR de 15 ciclos/min para a sÃ­ndrome de apneia central do sono. ApÃ³s seis meses de tratamento, a polissonografia com SVA mostrou uma
melhoria do Ã­ndice de distÃºrbio respiratÃ³rio para 4,8 eventos/h e tempo de registro com saturaÃ§Ã£o da oxi-hemoglobina < 90% de 1,4% (Figura
3). Verificou-se tambÃ©m uma melhoria das trocas gasosas (FiO2 = 0,21; pH = 7,36; PaO2 = 69 mmHg; PaCO2 = 46 mmHg; e SaO2 = 93%). Figura
3Registro polissonogrÃ¡fico com o uso de servoventilador mostrando a correÃ§Ã£o das apneias centrais. A MC-I tem sido definida como um
deslocamento caudal das amÃ­gdalas cerebelares acima de 5 mm atravÃ©s do forÃ¢men magno e Ã© geralmente associada a uma fossa posterior
volumetricamente reduzida.( 1 ) Esses critÃ©rios radiolÃ³gicos devem ser enquadrados no contexto clÃ­nico para o diagnÃ³stico, e a ressonÃ¢ncia
magnÃ©tica Ã© o estudo de imagem mais Ãºtil. O centro respiratÃ³rio responsÃ¡vel pelo controle da respiraÃ§Ã£o situa-se no bulbo raquidiano ao
nÃ­vel da transiÃ§Ã£o craniocervical e pode ser afetado nessa patologia, conduzindo assim a distÃºrbios respiratÃ³rios, especialmente durante o
sono.( 4 ) Os estudos publicados na literatura tÃªm demonstrado uma elevada prevalÃªncia de distÃºrbios respiratÃ³rios do sono em pacientes com
MC.(5,6) Na maioria dos casos em adultos, tÃªm sido documentadas sobretudo apneias centrais do sono, mas tambÃ©m tÃªm sido reportadas apneias
mistas e obstrutivas.( 7 , 8 ) As apneias centrais poderiam resultar da compressÃ£o direta dos componentes respiratÃ³rios centrais, da
compressÃ£o dos pares de nervos cranianos IX e X e da lesÃ£o dos nervos aferentes pelas cavidades siringomiÃ©licas.( 9 ) A hipoventilaÃ§Ã£o Ã©
definida como a dessaturaÃ§Ã£o de oxigÃªnio de forma sustentada que nÃ£o estÃ¡ associada a apneias obstrutivas, hipopneias ou respiraÃ§Ã£o
periÃ³dica.( 10 ) Os pacientes com hipercapnia diurna, principalmente devido a doenÃ§a neuromuscular ou anormalidades do controle ventilatÃ³rio
(sÃ­ndrome de hipoventilaÃ§Ã£o da obesidade e hipoventilaÃ§Ã£o alveolar central), podem apresentar tambÃ©m apneias centrais durante o sono.( 11 )
Os eventos centrais caracterizam-se pela cessaÃ§Ã£o transitÃ³ria do estÃ­mulo neuronal respiratÃ³rio durante o sono, resultando em diminuiÃ§Ã£o da
ventilaÃ§Ã£o e alteraÃ§Ã£o das trocas gasosas.( 12 ) De um modo geral, as apneias centrais durante o sono devem ser distinguidas entre pacientes
que apresentam hipercapnia e aqueles que apresentam normocapnia ou hipocapnia. A apneia central do sono hipercÃ¡pnica sobrepÃµe-se Ã s
sÃ­ndromes de hipoventilaÃ§Ã£o e Ã© considerada como uma parte integrante da sÃ­ndrome de hipoventilaÃ§Ã£o do sono.( 11 ) No caso descrito,
existiam alteraÃ§Ãµes da funÃ§Ã£o respiratÃ³ria, caracterizadas por uma reduÃ§Ã£o ligeira da CVF acompanhada da diminuiÃ§Ã£o do volume de reserva
expiratÃ³ria. No paciente obeso hÃ¡ um comprometimento da mecÃ¢nica respiratÃ³ria que provoca alteraÃ§Ãµes da funÃ§Ã£o pulmonar, com o aumento do
trabalho respiratÃ³rio e a reduÃ§Ã£o dos volumes pulmonares. A restriÃ§Ã£o ventilatÃ³ria associada Ã  obesidade Ã© geralmente leve e Ã© atribuÃ­da aos
efeitos mecÃ¢nicos da acumulaÃ§Ã£o de tecido adiposo sobre o diafragma e a parede torÃ¡cica: a excursÃ£o do diafragma Ã© prejudicada e a
complacÃªncia torÃ¡cica encontra-se diminuÃ­da. ( 13 ) A reduÃ§Ã£o do volume de reserva expiratÃ³ria pode ser detectÃ¡vel mesmo em pacientes com um
aumento modesto de peso. Em casos de obesidade mÃ³rbida, essa alteraÃ§Ã£o pode ser acompanhada de uma reduÃ§Ã£o da CPT e da capacidade residual
funcional.( 14 ) Alguns pacientes obesos apresentam hipoventilaÃ§Ã£o alveolar. O mecanismo pelo qual a obesidade conduz Ã  hipoventilaÃ§Ã£o Ã©
complexo e nÃ£o se encontra totalmente compreendido. VÃ¡rios mecanismos tÃªm sido propostos, incluindo alteraÃ§Ã£o da mecÃ¢nica ventilatÃ³ria,
respostas centrais diminuÃ­das para hipercapnia e hipÃ³xia e alteraÃ§Ãµes neuro-hormonais, como resistÃªncia Ã  leptina.( 15 ) A sÃ­ndrome de
obesidade/hipoventilaÃ§Ã£o Ã© definida como uma combinaÃ§Ã£o de obesidade (Ã­ndice de massa corpÃ³rea â‰¥ 30 kg/m2), hipercapnia diurna e vÃ¡rios
tipos de distÃºrbios respiratÃ³rios do sono apÃ³s a exclusÃ£o de outras patologias que podem originar hipoventilaÃ§Ã£o alveolar (doenÃ§as
pulmonares obstrutivas ou restritivas, patologias da parede torÃ¡cica e doenÃ§as neuromusculares).( 16 ) Pacientes com distÃºrbios
neurolÃ³gicos, incluindo a MC, podem apresentar hipoventilaÃ§Ã£o central. ( 17 ) Contudo, a hipoventilaÃ§Ã£o alveolar associada a apneias
centrais nÃ£o Ã© frequente na MC-I, e, no presente caso, nÃ£o se pode excluir o papel da obesidade nas alteraÃ§Ãµes observadas na gasometria
arterial. A cirurgia descompressiva habitualmente resulta na diminuiÃ§Ã£o dos eventos respiratÃ³rios durante o sono e reduz a fragmentaÃ§Ã£o do
sono em um nÃºmero significativo de pacientes, efeitos mais pronunciados naqueles com apneias centrais. ( 3 ) No entanto, hÃ¡ relatos de
aparecimento de apneias centrais apÃ³s cirurgia.( 18 ) A SVA Ã© um modo ventilatÃ³rio controlado por pressÃ£o e em ciclos por volume ou pico de
fluxo. A SVA corrige as apneias centrais, fornecendo um ajuste dinÃ¢mico (respiraÃ§Ã£o por respiraÃ§Ã£o) da pressÃ£o de suporte inspiratÃ³ria com
uma frequÃªncia respiratÃ³ria de backup para normalizar o padrÃ£o respiratÃ³rio. A eficÃ¡cia da SVA tem sido demonstrada sobretudo no tratamento
da sÃ­ndrome de apneia central do sono associada a insuficiÃªncia cardÃ­aca congestiva. Na sÃ­ndrome de apneia central do sono associada a
distÃºrbios neurolÃ³gicos (sem respiraÃ§Ã£o periÃ³dica do tipo Cheyne-Stokes), o papel da SVA nÃ£o se encontra ainda bem estabelecido.( 19 ) O
caso clÃ­nico demonstra a eficÃ¡cia da SVA no tratamento da sÃ­ndrome de apneia central do sono associada a hipoventilaÃ§Ã£o alveolar em uma
paciente com MC-I, pois observou-se uma completa resoluÃ§Ã£o dos eventos centrais e uma melhoria significativa das trocas gasosas. AlÃ©m disso,
o caso sugere que a SVA pode ser eficaz no tratamento de apneia central do sono associada a MC-I apÃ³s a descompressÃ£o cirÃºrgica. Na
literatura publicada, foi encontrada apenas uma referÃªncia a um caso clÃ­nico idÃªntico.( 20 ) Desse modo, a SVA pode ser uma alternativa Ã 
cirurgia descompressiva no tratamento da apneia central do sono associada a MC-I. GostarÃ­amos de agradecer ao Dr. Nuno Canto Moreira a sua
contribuiÃ§Ã£o na anÃ¡lise das imagens de ressonÃ¢ncia magnÃ©tica. Apoio financeiro: Nenhum Trabalho realizado no ServiÃ§o de Pneumologia, Centro
Hospitalar Tondela-Viseu, Viseu, Portugal
